Center-Authored Papers

Filters: Author is Kuderer, Nicole M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Warfarin
Kuderer NM, Khorana AA, Lyman GH, Francis CW.  2007.  A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications.. Cancer. 110(5):1149-61. Abstract
Venous Thrombosis
Khorana AA, Francis CW, Culakova E, Fisher RI, Kuderer NM, Lyman GH.  2006.  Thromboembolism in hospitalized neutropenic cancer patients.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 24(3):484-90. Abstract
Lyman GH, Khorana AA, Kuderer NM, Lee AY.  2009.  Cancer and thrombosis: back to the future renewed interest in an old problem.. Cancer investigation. 27(5):472-3. Abstract
Venous Thromboembolism
Connolly GC, Khorana AA, Kuderer NM, Culakova E, Francis CW, Lyman GH.  2010.  Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy.. Thrombosis research. 126(2):113-8. Abstract
Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH.  2007.  Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients.. Cancer. 110(10):2339-46. Abstract
Lyman GH, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE et al..  2013.  Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(17):2189-204. Abstract
Lyman GH, Kuderer NM.  2010.  Prevention and treatment of venous thromboembolism among patients with cancer: the American Society of Clinical Oncology Guidelines.. Thrombosis research. 125 Suppl 2:S120-7.
Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers C, Jahanzeb M, Kakkar A, Kuderer NM, Levine MN, Liebman H et al..  2007.  American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(34):5490-505. Abstract
Lyman GH, Bohlke K, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW et al..  2015.  Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(6):654-6. Abstract
Urinary Bladder Neoplasms
Lyman GH, Kuderer NM, Freedland SJ.  2009.  Does treatment intensity matter in superficial bladder cancer? Consensus, clinical practice, and confounding. Journal of the National Cancer Institute. 101(8):543-5.
United States
Khorana AA, Francis CW, Culakova E, Fisher RI, Kuderer NM, Lyman GH.  2006.  Thromboembolism in hospitalized neutropenic cancer patients.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 24(3):484-90. Abstract
Kuderer NM, Lyman GH.  2011.  Personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy.. Journal of the National Cancer Institute. 103(12):910-3.
Lyman GH, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE et al..  2013.  Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(17):2189-204. Abstract
Crawford J, Dale DC, Kuderer NM, Culakova E, Poniewierski MS, Wolff D, Lyman GH.  2008.  Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice.. Journal of the National Comprehensive Cancer Network : JNCCN. 6(2):109-18. Abstract
Lyman GH, Kuderer NM.  2010.  Prevention and treatment of venous thromboembolism among patients with cancer: the American Society of Clinical Oncology Guidelines.. Thrombosis research. 125 Suppl 2:S120-7.
Treatment Outcome
Lyman GH, Dale DC, Wolff DA, Culakova E, Poniewierski MS, Kuderer NM, Crawford J.  2010.  Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic review.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(17):2914-24. Abstract
Lyman GH, Cosler LE, Kuderer NM, Hornberger J.  2007.  Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer: an economic analysis based on prognostic and predictive validation studies.. Cancer. 109(6):1011-8. Abstract
Kuderer NM, Dale DC, Crawford J, Lyman GH.  2007.  Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(21):3158-67. Abstract
Lyman GH, Kuderer NM.  2002.  Filgrastim in patients with neutropenia: potential effects on quality of life.. Drugs. 62 Suppl 1:65-78. Abstract
Kuderer NM, Khorana AA, Lyman GH, Francis CW.  2007.  A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications.. Cancer. 110(5):1149-61. Abstract
Kuderer NM, Lyman GH.  2009.  Gene expression profile assays as predictors of distant recurrence-free survival in early-stage breast cancer.. Cancer investigation. 27(9):885-90.
Time Factors
Cosler LE, Eldar-Lissai A, Culakova E, Kuderer NM, Dale D, Crawford J, Lyman GH.  2007.  Therapeutic use of granulocyte colony-stimulating factors for established febrile neutropenia: effect on costs from a hospital perspective.. PharmacoEconomics. 25(4):343-51. Abstract
Kuderer NM, Lyman GH.  2009.  Gene expression profile assays as predictors of distant recurrence-free survival in early-stage breast cancer.. Cancer investigation. 27(9):885-90.
Thrombosis
Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW.  2008.  Development and validation of a predictive model for chemotherapy-associated thrombosis.. Blood. 111(10):4902-7. Abstract
Thrombolytic Therapy
Lyman GH, Khorana AA, Kuderer NM, Lee AY.  2009.  Cancer and thrombosis: back to the future renewed interest in an old problem.. Cancer investigation. 27(5):472-3. Abstract